People and populations differ in their desired and adverse responses to pharmaceuticals. Multiple genes and nutritional, metabolic, environmental, and lifestyle behavioral factors are variables. Recent advances in genetic technology make it feasible to test many genes simultaneously, even the entire genome, rather than just one gene at a time. This chapter presents a framework for pharmacogenetics and pharmacogenomics, with specific applications to clinical practice and to development of new drugs, especially for cancers.